USD
+$0.00
(+0.00%
)At Close (As of Sep 15, 2025)
$5.17M
Market Cap
-
P/E Ratio
-172.7
EPS
$94.71
52 Week High
$4.71
52 Week Low
HEALTHCARE
Sector
Field | Value (USD) |
---|---|
Gross Profit | $1.5M |
Total Revenue | $2.6M |
Cost Of Revenue | $1.1M |
Costof Goods And Services Sold | $1.1M |
Operating Income | -$3.6M |
Selling General And Administrative | $3.5M |
Research And Development | $909K |
Operating Expenses | $5.1M |
Investment Income Net | - |
Net Interest Income | -$104K |
Interest Income | - |
Interest Expense | $135K |
Non Interest Income | - |
Other Non Operating Income | - |
Depreciation | - |
Depreciation And Amortization | $1K |
Income Before Tax | -$3.7M |
Income Tax Expense | $19K |
Interest And Debt Expense | - |
Net Income From Continuing Operations | -$3.7M |
Comprehensive Income Net Of Tax | - |
Ebit | -$3.7M |
Ebitda | -$3.7M |
Net Income | -$3.7M |
Field | Value (USD) |
---|---|
Total Assets | $3.6M |
Total Current Assets | $3.3M |
Cash And Cash Equivalents At Carrying Value | $752K |
Cash And Short Term Investments | $752K |
Inventory | $2.2M |
Current Net Receivables | $268K |
Total Non Current Assets | $298K |
Property Plant Equipment | - |
Accumulated Depreciation Amortization Ppe | - |
Intangible Assets | - |
Intangible Assets Excluding Goodwill | - |
Goodwill | - |
Investments | - |
Long Term Investments | - |
Short Term Investments | - |
Other Current Assets | $120K |
Other Non Current Assets | - |
Total Liabilities | $3M |
Total Current Liabilities | $2.7M |
Current Accounts Payable | $47K |
Deferred Revenue | - |
Current Debt | - |
Short Term Debt | $52K |
Total Non Current Liabilities | $280K |
Capital Lease Obligations | $116K |
Long Term Debt | - |
Current Long Term Debt | - |
Long Term Debt Noncurrent | - |
Short Long Term Debt Total | $116K |
Other Current Liabilities | $2.6M |
Other Non Current Liabilities | - |
Total Shareholder Equity | $627K |
Treasury Stock | - |
Retained Earnings | -$70M |
Common Stock | $3K |
Common Stock Shares Outstanding | $270K |
Field | Value (USD) |
---|---|
Operating Cashflow | -$2.5M |
Payments For Operating Activities | - |
Proceeds From Operating Activities | - |
Change In Operating Liabilities | - |
Change In Operating Assets | - |
Depreciation Depletion And Amortization | $1K |
Capital Expenditures | $3K |
Change In Receivables | - |
Change In Inventory | $541K |
Profit Loss | - |
Cashflow From Investment | -$3K |
Cashflow From Financing | $1K |
Proceeds From Repayments Of Short Term Debt | - |
Payments For Repurchase Of Common Stock | - |
Payments For Repurchase Of Equity | - |
Payments For Repurchase Of Preferred Stock | - |
Dividend Payout | - |
Dividend Payout Common Stock | - |
Dividend Payout Preferred Stock | - |
Proceeds From Issuance Of Common Stock | - |
Proceeds From Issuance Of Long Term Debt And Capital Securities Net | - |
Proceeds From Issuance Of Preferred Stock | - |
Proceeds From Repurchase Of Equity | - |
Proceeds From Sale Of Treasury Stock | - |
Change In Cash And Cash Equivalents | - |
Change In Exchange Rate | - |
Net Income | -$3.7M |
Field | Value (USD) |
---|---|
Gross Profit | $1.5M |
Total Revenue | $2.6M |
Cost Of Revenue | $1.1M |
Costof Goods And Services Sold | $1.1M |
Operating Income | -$3.6M |
Selling General And Administrative | $3.5M |
Research And Development | $909K |
Operating Expenses | $5.1M |
Investment Income Net | - |
Net Interest Income | -$104K |
Interest Income | - |
Interest Expense | $135K |
Non Interest Income | - |
Other Non Operating Income | - |
Depreciation | - |
Depreciation And Amortization | $1K |
Income Before Tax | -$3.7M |
Income Tax Expense | $19K |
Interest And Debt Expense | - |
Net Income From Continuing Operations | -$3.7M |
Comprehensive Income Net Of Tax | - |
Ebit | -$3.7M |
Ebitda | -$3.7M |
Net Income | -$3.7M |
Sector: HEALTHCARE
Industry: MEDICAL DEVICES
NanoVibronix, Inc., through its subsidiary, NanoVibronix Ltd., focuses on the manufacture and sale of non-invasive biological response activating devices that focus on biofilm prevention, wound healing, and pain therapy. The company is headquartered in Elmsford, New York.